140 Summer Partners’s Elevance Health ELV Stock Holding History

140 Summer Partners’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-90,400	Closed	-$33.3M	–	22
2024 Q4	$33.3M	Sell	90,400 -42,659	-32%	-$17.9M	3.99%	13
2024 Q3	$69.2M	Buy	133,059 +46,800	+54%	+$25M	7.45%	6
2024 Q2	$46.7M	Sell	86,259 -29,100	-25%	-$15.4M	5.63%	8
2024 Q1	$59.8M	Buy	115,359 +41,150	+55%	+$20.5M	7.42%	6
2023 Q4	$35M	Buy	74,209 +8,708	+13%	+$4.03M	6.03%	9
2023 Q3	$28.5M	Sell	65,501 -74,500	-53%	-$33.8M	5.56%	10
2023 Q2	$62.2M	Buy	140,001 +7,200	+5%	+$3.32M	13.81%	2
2023 Q1	$61.1M	Buy	132,801 +38,900	+41%	+$18.5M	10.95%	3
2022 Q4	$48.2M	Buy	+93,901	New	+$47.7M	9.36%	4

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

140 Summer Partners's ELV Position: Q1 2025 in Review

140 Summer Partners sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 90,400 shares — an estimated $33.3M sold.

140 Summer Partners first reported a position in ELV in Q4 2022 and held it in 9 quarters. The position peaked at $69.2M in Q3 2024. 1,661 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

140 Summer Partners reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
140 Summer Partners sold 90,400 Elevance Health shares in Q1 2025, an estimated $33.3M.
140 Summer Partners first reported a position in Elevance Health in Q4 2022 and held it in 9 quarters.
140 Summer Partners's Elevance Health position peaked at $69.2M in Q3 2024.
1,661 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on 140 Summer Partners's 13F filing for Q1 2025, filed 15 May 2025.